Transcode Therapeutics, Inc.
Clinical-stage oncology company developing RNA-based therapeutics for metastatic cancer.
RNAZ | US
Overview
Corporate Details
- ISIN(s):
- US89357L1052
- LEI:
- Country:
- United States of America
- Address:
- 6 LIBERTY SQUARE, 2109 BOSTON
Description
Transcode Therapeutics, Inc. is a clinical-stage oncology company developing RNA-based therapeutics for metastatic cancer. The company's strategy focuses on the specific eradication of metastatic tumor cells by targeting microRNA-10b (miRNA-10b), identified as a master regulator of metastasis. Its lead therapeutic candidate, TTX-MC138, is an oligonucleotide designed to inhibit miRNA-10b. Transcode utilizes a proprietary iron oxide nanoparticle delivery platform, TTX, to transport its therapeutic candidates to tumor sites. Pre-clinical studies in murine models have demonstrated that TTX-MC138 can induce regression of established metastases in breast and pancreatic cancers. The company's approach has potential applicability across numerous cancer types where miRNA-10b is involved, including breast, pancreatic, ovarian, and colon cancers, as well as glioblastomas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Transcode Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Transcode Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Transcode Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
